It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
This video will be soon available

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login

Worldwide schedules comment Share
Prof. Dr. Eric Van Cutsem, UZ Leuven
Current treatment landscape with anti-PD-1 therapy for advanced esophageal cancer
Prof. Dr. Marc Van den Eynde, Cliniques Universitaires Saint-Luc, Brussels
20:00 GI immune related adverse events management with anti-PD-1 therapy
Prof. Dr. Marc Peeters, UZ Antwerpen
20:30 CPS testing in esophageal cancer
Dr. Vasiliki Siozopoulou, UZ Antwerpen
20h40 Q&A session
Moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven
21:10 Closing

In collaboration with

MSD Belgium SRL / BV
Clos du Lynx, 5, Lynx Binnernhof - Bruxelles 1200 Brussel


UZ: Universitair Ziekenhuis
PD-1: Programmed death ligand 1
CPS: Combined Positive Score
Q&A: Questions and answers
Date of last revision: 08/2021

Shooting date : 2021-10-11
Last update : 2021-10-25


There is no video available at the moment
Scroll Up